Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Patient Enrollment Complete For Phase I/II Clinical Trial For GALNS For Morquio A Syndrome
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that patient enrollment has been completed for the Phase I/II clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. The company expects to report initial results in the first half of 2010.

Limbal Stem Cells - To Be Or Not To Be?
There has been a recent questioning of the role of the limbal stem cell in corneal maintenance and the recent Association for Research in Vision and Ophthalmology (ARVO) meeting in Fort Lauderdale May 3 -7, 2009 saw some fairly hot debate son this topic. Professor Colin Green, University of Auckland, New Zealand reviews an interesting series of sessions for The Society for Clinical Ophthalmology.
News of the day
Jazz Pharmaceuticals To Present Data From First Phase III Study Of Sodium Oxybate In Patients With Fibromyalgia
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that data from the company"s first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the Associated Professional Sleep Societies (APSS) 2009 Annual Meeting in Seattle, Washington and also during the European League Against Rheumatism (EULAR) Congress in Copenhagen, Denmark.
Health Insurance

Agave Nectar Does Not Comply With FDA Labeling Laws

Agave nectar is an alternative sweetener used in health food bars and sold as a replacement for sugar, honey and maple syrup. Alternative health writer Ramiel Nagel has announced today that agave nectar does not contain a correct label as required by FDA labeling laws. "Agave nectar contains 70%-75% highly chemically refined fructose-more than is present in high fructose corn syrup-and most consumers don"t know this," explained Mr. Nagel. Once eaten, refined fructose appears as triglycerides in the bloodstream, or is stored as body fat. Elevated triglyceride levels, caused by consumption of refined fructose, is one of the factors responsible for the hardening of human arteries. Further, metabolic studies have proven the relationship between refined fructose consumption and obesity. Fructose in agave nectar is a man-made synthetic sugar produced through a complex process of enzyme hydrolysis which converts non-sweet starches and sugars into a highly refined sweetener, fructose. Russ Bianchi, Managing Director and CEO of Adept Solutions, Inc., a globally recognized food and beverage development firm, explains, "By eating high fructose syrups, you are clogging the arteries, creating inflammation, and increasing body fat, while stressing your heart. This is in part because refined fructose is foreign to the body, and is not recognized by it." A confidential letter from the FDA explains that agave nectar is supposed to be labeled as "hydrolyzed inulin syrup," to reveal its true nature. Yet as of today, no agave manufacturers comply with the FDA"s labeling requirement. These manufacturers are not adhering to the law, and as a result, consumers are unaware of the high fructose content of agave nectar. Nagel"s research reveals that due to its high fructose content agave nectar may not be safe for pregnant women, and that when used frequently it may cause body chemistry imbalances that can promote poor health, in the same why high fructose corn syrup would. Please contact us to learn more. Ramiel Nagel


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009